The Scorpion Therapeutics spinoff sold rights for two EGFR inhibitors to Pierre Fabre Laboratories and is hoping to become a clinical-stage firm by 2026.

Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...

Only 25% of AI projects meet ROI goals. IBM argues the solution is strategy-first, not more hype. Learn how to scale AI with ...

Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we ...

NVIDIA partners with Swedish businesses to establish a new AI technology centre enhancing industry capabilities ...

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

How AI is reshaping biotech through partnerships, from drug discovery to clinical trials, and what it means for the future of ...

At Snowflake Summit 2025, CEO Sridhar Ramaswamy and OpenAI’s Sam Altman charted the course for accelerating enterprise AI ...

Partnership with Mace includes the installation of 108 laboratory fume cupboards Greater Manchester, UK – 8th April 2025 – Envair Technology, a leading specialist in clean air and containment ...

Phenomenex Inc., a Danaher Company, a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced the expansion of its product portfolio at ASMS ...

After rapid expansion, signs of a slowdown raise questions about future opportunities in the sector When it emerged that ...

A group of leading Swedish businesses and organisations – including AstraZeneca, Ericsson, Saab, SEB and Wallenberg ...